Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date14 Dec 2021 |
虎贞通风胶囊与安慰剂对照治疗急性通风性关节炎(湿热蕴结症)随机、双盲、多中心临床试验
[Translation] A randomized, double-blind, multicenter clinical trial of Huzhen Tongfeng Capsule versus placebo in the treatment of acute ventilatory arthritis (damp-heat accumulation syndrome)
以安慰剂对照,评价虎贞通风胶囊治疗急性通风性关节炎(湿热蕴结症)的有效性、安全性。
[Translation] To evaluate the efficacy and safety of Huzhen Tongfeng Capsule in the treatment of acute ventilation arthritis (damp-heat accumulation syndrome) using a placebo control.
虎贞痛风胶囊与安慰剂对照治疗急性痛风性关节炎 (湿热蕴结证)随机、双盲、多中心临床试验
[Translation] A randomized, double-blind, multicenter clinical trial of Huzhen Tongfeng Capsule versus placebo in the treatment of acute gouty arthritis (damp-heat accumulation syndrome)
以安慰剂对照,初步评价虎贞痛风胶囊治疗急性痛风性关节炎(湿热蕴结证)的有效性、安全性。
[Translation] Using placebo as a control, we preliminarily evaluated the efficacy and safety of Huzhen Gout Capsule in the treatment of acute gouty arthritis (syndrome of damp-heat accumulation).
100 Clinical Results associated with Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.
0 Patents (Medical) associated with Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.
100 Deals associated with Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.
100 Translational Medicine associated with Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.